4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001493152-25-018917
10% owner sold 330,210 shares at an average $6.23 ($2,058,247)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SVF Endurance (Cayman) Ltd 10% owner | 2025-10-20 | Sale 10b5-1 | −220,535 | $6.20 | $1,367,273 | 15,119,959 | I |
| SVF Endurance (Cayman) Ltd 10% owner | 2025-10-21 | Sale 10b5-1 | −109,675 | $6.30 | $690,974 | 15,010,284 | I |
| Open-market sales · 330,210 sh · avg $6.23 · $2,058,247 | |||||||
Loading xslF345X05/ownership.xml…